Related Experiment Video
Updated: Jan 10, 2026

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
Association of Systemic Inflammatory Response Index (SIRI) With Severity of Coronary Artery Disease in Patients With
Wenli Chen1, Yuanyuan He1, Cun Xie2,3
1Tianjin University of Traditional Chinese Medicine, China.
Insights
The systemic inflammation response index (SIRI) can help determine coronary heart disease (CHD) severity. Higher SIRI levels are linked to more severe CHD, especially in females and older adults.
Area of Science:
- Cardiology
- Inflammation Biomarkers
- Public Health
Background:
- The systemic inflammation response index (SIRI) is a novel biomarker for chronic inflammation.
- Coronary heart disease (CHD) remains a leading cause of mortality worldwide.
- Assessing CHD severity is crucial for effective patient management.
Purpose of the Study:
- To evaluate the clinical utility of SIRI in determining the severity of coronary heart disease (CHD).
- To investigate the association between SIRI levels and the extent of coronary artery disease.
Main Methods:
- Analysis of data from the Cohort Study on the Treatment of Cardiovascular Diseases with Traditional Chinese Medicine (CSCD-TCMplus).
- Participants (n=7706) were categorized into tertiles based on SIRI values.
- Logistic regression analysis was employed to assess the relationship between SIRI and CHD severity (number of diseased vessels).
Main Results:
- A significant association was found between higher SIRI levels and increased CHD severity (OR: 1.09, 95% CI: 1.03-1.15).
- Females and individuals over 55 years old showed a higher risk of severe CHD with elevated SIRI.
- The association remained significant after adjusting for confounding factors.
Conclusions:
- SIRI is a valuable biomarker for assessing CHD severity.
- Inflammation, as indicated by SIRI, plays a significant role in the progression of coronary heart disease.
- Further research may explore SIRI's role in guiding treatment strategies for CHD.
Abstract:
The systemic inflammation response index (SIRI) is a novel inflammatory biomarker that reflects the chronic inflammatory status. This study aimed to evaluate its clinical utility in determining coronary heart disease (CHD) severity. Participants in this study, sourced from the Cohort Study on the Treatment of Cardiovascular Diseases with Traditional Chinese Medicine (CSCD-TCMplus), were divided into tertiles (T) based on their SIRI values. The number of diseased vessels (single- and multi-vessel CHD) was used as a measure of disease severity, assessed by coronary angiography. Logistic regression analysis was used to investigate the relationship between SIRI and the severity of CHD. Among the 7706 participants, 6215 (80.6%) had multi-vessel disease. Logistic regression analysis revealed a significant association between SIRI and CHD severity (odds ratio [OR]: 1.09; 95% confidence interval [CI]: 1.03-1.15). Compared with males, females had a higher risk of CHD severity at the SIRI T3 tertile (OR: 1.64; 95% CI: 1.28-2.10). Also, patients >55 years of age had a greater risk than those ≤55 years old (OR: 1.93; 95% CI: 1.67-2.01). The association between SIRI and CHD severity persisted even after adjusting for confounding factors.
More Related Videos
06:16Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
Published on: August 9, 2024
06:57Author Spotlight: Advancing Cardiovascular Imaging - Introducing the Spatially Weighted Calcium Score for Early Disease Detection
Published on: September 22, 2023
Related Concept Videos
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome III: Diagnostic Studies
Coronary Artery Disease I: Introduction
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Acute Coronary Syndrome IV: Interprofessional Care
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations